9.0 Protocol Violations, Deviations, and Exceptions 9.1 ...
approved via expedited review procedures, or determined by the convened IRB to meet expedited review criteria) may be eligible for expedited review. The IRB Chair or ... For Federal reporting purposes the IRB will need to determine whether the protocol violation constitutes an instance of serious or continuing non-compliance. If the violation
Download 9.0 Protocol Violations, Deviations, and Exceptions 9.1 ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
The Importance of Dairy Products
www.pbrc.eduThe Importance of Dairy Products Pennington Nutrition Series No 79 Healthier lives through education in nutrition and preventive medicine . Pennington Biomedical Research CenterPennington Biomedical Research Center 9400 Perkins Road Baton Rouge, LA 70808 …
Complications of Diabetes
www.pbrc.edu• The longer a person has diabetes, the higher the risk for developing diabetic retinopathy. If left untreated, diabetic retinopathy can cause blindness. • There are two major types of retinopathy: nonproliferative and proliferative. 1.Nonproliferative is the early stage and there are usually no or mild symptoms.
Related documents
Personnel Separations Disability Evaluation for Retention ...
armypubs.army.milthe proponent agency or its direct reporting unit or field operating agency, in the grade of colonel or the civilian equivalent. (This includes delegation to the Commanding General, U.S. Army Physical Disability Agency). Activities may request a waiver to this regulation by providing justification that includes a full analysis of the expected
NATIONAL DEFENSE AUTHORIZATION ACT FOR FISCAL …
www.congress.govNATIONAL DEFENSE AUTHORIZATION ACT FOR FISCAL YEAR 2018 rfrederick on DSKBCBPHB2PROD with HEARINGS VerDate Sep 11 2014 12:45 Nov 11, 2017 Jkt 027384 PO 00000 Frm 00002 Fmt 6019 Sfmt 6019 E:\HR\OC\HR404.XXX HR404
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euModalities for expedited reporting ..... 56 106 VI.Appendix 3.1. Interim arrangements ..... 56 VI.Appendix 3.1.1. Interim arrangements applicable to marketing authorisation holders ....107 61 108 VI.Appendix 3.1.2. Interim arrangements applicable to competent authorities in Member